See how the Jefferson Heart Care team helped Tom Take a Virtual Tour - Heart Care at Jefferson     Jarvik 2000 ® Heart Assist System – Offering More Options for Patients with Heart Failure Part of an FDA-authorized clinical trial, the Jarvik 2000 ® Heart Assist System is currently only available in Pennsylvania at Jefferson.     Schedule an Appointment Call 215-955-2050 or 1-800-JEFF-NOW. Arrangements can be made so that you can coordinate your appointments with all of your heart failure specialists on the same day at the Center. Location The Center is located in Philadelphia at 925 Chestnut Street, Mezzanine level. Get Directions. Hours Monday through Friday from 8 a.m. until 5 p.m.

New Target For Heart Failure Therapy Identified
A novel signaling pathway plays a significant role in the production of aldosterone, a hormone that promotes heart failure after a myocardial infarction, according to a study conducted by Thomas Jefferson University researchers.

Double Duty: Loss of Protective Heart Failure Protein Causes High Blood Pressure
Scientists at the Center for Translational Medicine at Thomas Jefferson University in Philadelphia have found that a protein that appears to have protective and perhaps healing effects for failing hearts also plays a similar role in high blood pressure. They found lower-than-normal levels of the protein S100A1 in cells that line blood vessel walls in animals with high blood pressure.

Gene Therapy Reversed Heart Damage in Heart Failure
Long-term gene therapy resulted in improved cardiac function and reversed deterioration of the heart in rats with heart failure, according to a recent study conducted by researchers at Thomas Jefferson University’s Center for Translational Medicine. The study was published online in Circulation.

Jefferson Heart Failure Specialist Offers Hope Against a Once Intractable Disease
Heart failure is the only cardiac related disease that is actually growing in the United States. Yet even though it is striking more and more patients at younger ages, there is reason for hope according to Sharon Rubin, M.D., a heart failure specialist at the Jefferson Heart Institute at Thomas Jefferson University Hospital in Philadelphia.

Jefferson Researchers Find Potential Biomarker for Heart Failure
A team of cardiology researchers at Thomas Jefferson University has determined that GRK2, a protein that plays an important regulatory role in heart failure, is elevated in patients with failing hearts when compared to patients with normal heart function.

Jefferson Receives Medicare Approval for its Advanced Heart Failure and Cardiac Transplant Center
The Advanced Heart Failure and Cardiac Transplant Center at Thomas Jefferson University Hospital has become one of only 96 adult and six pediatric heart transplant centers in the nation approved by Medicare.